Found: 1

Select item for more details and to access through your institution.

  • Dose adjusted- EPOCH-R and mediastinal disease may improve outcomes for patients with gray-zone lymphoma.

    Published in:
    British Journal of Haematology, 2017, v. 179, n. 3, p. 503, doi. 10.1111/bjh.14226
    By:
    • Chihara, Dai;
    • Westin, Jason R.;
    • Miranda, Roberto N.;
    • Cheah, Chan Y.;
    • Oki, Yasuhiro;
    • Turturro, Francesco;
    • Romaguera, Jorge E.;
    • Neelapu, Sattva S.;
    • Nastoupil, Lorreta J.;
    • Fayad, Luis E.;
    • Rodriguez, M. Alma;
    • Fowler, Nathan H.;
    • Orlowski, Robert Z.;
    • Wang, Michael;
    • Hagemeister, Fredrick B.;
    • Medeiros, L. Jeffrey;
    • Fanale, Michelle A.
    Publication type:
    Article